Suppr超能文献

现代时代复发性头颈部癌症放射治疗的进展。

Advancements of radiotherapy for recurrent head and neck cancer in modern era.

机构信息

Department of Head and Neck Oncology, Cancer Center, West China Hospital, SCU, Chengdu, Sichuan, China.

Department of Radiation Oncology, Cancer Center, West China Hospital, SCU, Chengdu, Sichuan, China.

出版信息

Radiat Oncol. 2023 Oct 6;18(1):166. doi: 10.1186/s13014-023-02342-0.

Abstract

Head and neck cancer is a kind of cancer which can be eradicated from radical radiation therapy. However, with best efforts, nearly 40% patients will experience locoregional recurrence. Locoregional recurrence is the main cause of cancer-related death in head and neck cancers, so local treatments play a key role in improving progression free survival. In the last decades, radiation techniques have been tremendously developed, highly conformal radiation techniques such as intensity-modulated radiotherapy, stereotactic body radiation therapy, brachytherapy and proton or heavy ion radiation therapy have their unique radiobiological advances. Although reirradiation is widely used in clinical practice, but little is known when comparing the different techniques. In this review, we will provide a comprehensive overview of the role of reirradiation in recurrent head and neck cancers including radiation techniques, patient selection, overall clinical benefits, and toxicities.

摘要

头颈部癌症是一种可以通过根治性放射治疗来消除的癌症。然而,尽管付出了最大的努力,仍有近 40%的患者会出现局部区域复发。局部区域复发是头颈部癌症相关死亡的主要原因,因此局部治疗对于提高无进展生存率起着关键作用。在过去的几十年中,放射技术得到了极大的发展,调强放疗、立体定向体部放疗、近距离放疗以及质子或重离子放疗等高度适形放疗技术具有独特的放射生物学优势。尽管再放疗在临床实践中得到了广泛应用,但对于不同技术的比较,人们知之甚少。在这篇综述中,我们将全面概述再放疗在复发性头颈部癌症中的作用,包括放射技术、患者选择、总体临床获益和毒性。

相似文献

5

引用本文的文献

1
Immunotherapy in Head and Neck Cancer.头颈部癌症的免疫疗法
Cancer Treat Res. 2025;129:119-156. doi: 10.1007/978-3-031-97242-3_7.

本文引用的文献

2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验